Ningbo HicRen Biotechnology Co., Ltd.
PrivateLast Round
Strategic
Jun 10, 2025
Total Funding Raised
$14.8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ningbo HicRen Biotechnology Co., Ltd. operates in Healthcare & Life Sciences and is based in Ningbo. Its latest recorded funding round was a Pre-C Extension round in July 2023.
Ningbo HicRen Biotechnology Co., Ltd. is a medical device company that develops, manufactures, and markets innovative orthopedic and spinal surgery solutions, including minimally invasive vertebroplasty instruments and surgical robotics.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ningbo HicRen Biotechnology Co., Ltd. Comparables
Compare Ningbo HicRen Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Kinetic Medical Co., Ltd. | 82% | |
| Nanjing Perlove Medical Equipment | 79% | |
| Yijiahe Technology Co Ltd | 78% |
For institutional investors. Book with your work email.
Ningbo HicRen Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 10, 2025 | ||||
| Pre-C Extension | Jul 13, 2023 | ||||
| Early Funding | Jul 13, 2022 |
For institutional investors. Book with your work email.
Ningbo HicRen Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Series B |
| Chengshu Capital | Strategic |
| GP Healthcare Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Open roles increased to 18, 4.5x the trailing average.
- Jul 13, 2023
Completed a Pre-C Extension funding round.
For institutional investors. Book with your work email.
Ningbo HicRen Biotechnology Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ningbo HicRen Biotechnology Co., Ltd.'s valuation, stock price, and market status.
Is Ningbo HicRen Biotechnology Co., Ltd. a public or private company?
Ningbo HicRen Biotechnology Co., Ltd. is a private company.
What is the current stock price of Ningbo HicRen Biotechnology Co., Ltd.?
Ningbo HicRen Biotechnology Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Ningbo HicRen Biotechnology Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ningbo HicRen Biotechnology Co., Ltd. worth (valuation)?
Valuation information for Ningbo HicRen Biotechnology Co., Ltd. is not publicly available.
Can I buy Ningbo HicRen Biotechnology Co., Ltd. stock?
Ningbo HicRen Biotechnology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ningbo HicRen Biotechnology Co., Ltd.'s last funding round?
Ningbo HicRen Biotechnology Co., Ltd.'s most recent funding round was Strategic on June 10, 2025.
Who are the main investors in Ningbo HicRen Biotechnology Co., Ltd.?
Key investors in Ningbo HicRen Biotechnology Co., Ltd. include Hillhouse Investment, Chengshu Capital, GP Healthcare Capital.
Will Ningbo HicRen Biotechnology Co., Ltd. IPO soon?
No public IPO plans have been announced for Ningbo HicRen Biotechnology Co., Ltd..
How can I track Ningbo HicRen Biotechnology Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Ningbo HicRen Biotechnology Co., Ltd.'s shares on secondary markets.